RCDTF vs VRBCF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCDTF is a Hold and VRBCF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RCDTF’s FA Score shows that 1 FA rating(s) are green whileVRBCF’s FA Score has 2 green FA rating(s).
- RCDTF’s FA Score: 1 green, 4 red.
- VRBCF’s FA Score: 2 green, 3 red.
Price Growth
RCDTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.55%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was +2.00%.
Industries' Descriptions
@Pharmaceuticals: Major (-4.55% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| RCDTF | VRBCF | RCDTF / VRBCF | |
| Capitalization | 10.6B | 2.61B | 407% |
| EBITDA | 615M | 213M | 289% |
| Gain YTD | 13.587 | 32.639 | 42% |
| P/E Ratio | 26.11 | 29.33 | 89% |
| Revenue | 1.99B | 1.15B | 172% |
| Total Cash | 231M | 176M | 131% |
| Total Debt | 1.58B | 148M | 1,068% |
RCDTF | VRBCF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 21 Undervalued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 48 | 25 | |
SMR RATING 1..100 | 41 | 55 | |
PRICE GROWTH RATING 1..100 | 53 | 48 | |
P/E GROWTH RATING 1..100 | 62 | 74 | |
SEASONALITY SCORE 1..100 | 30 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RCDTF's Valuation (21) in the null industry is in the same range as VRBCF (30). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.
VRBCF's Profit vs Risk Rating (25) in the null industry is in the same range as RCDTF (48). This means that VRBCF’s stock grew similarly to RCDTF’s over the last 12 months.
RCDTF's SMR Rating (41) in the null industry is in the same range as VRBCF (55). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.
VRBCF's Price Growth Rating (48) in the null industry is in the same range as RCDTF (53). This means that VRBCF’s stock grew similarly to RCDTF’s over the last 12 months.
RCDTF's P/E Growth Rating (62) in the null industry is in the same range as VRBCF (74). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PWIYX | 18.30 | -0.01 | -0.05% |
| PACE International Equity Y | |||
| NBPIX | 47.58 | -0.09 | -0.19% |
| Neuberger Berman Large Cap Value Instl | |||
| FIDFX | 33.90 | -0.19 | -0.56% |
| Fidelity Advisor Mid Cap Value Z | |||
| VGLSX | 10.16 | -0.07 | -0.68% |
| VALIC Company I Global Strategy | |||
| MSJAX | 16.15 | -0.28 | -1.70% |
| Morgan Stanley Global Endurance A | |||
RCDTF and
Correlation & Price change
A.I.dvisor indicates that over the last year, RCDTF has been loosely correlated with VRBCF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCDTF jumps, then VRBCF could also see price increases.
| Ticker / NAME | Correlation To RCDTF | 1D Price Change % | ||
|---|---|---|---|---|
| RCDTF | 100% | N/A | ||
| VRBCF - RCDTF | 56% Loosely correlated | N/A | ||
| RHHBF - RCDTF | 3% Poorly correlated | -1.66% | ||
| RHHBY - RCDTF | 2% Poorly correlated | -0.83% | ||
| PTKFY - RCDTF | 0% Poorly correlated | -16.54% | ||
| PTKFF - RCDTF | 0% Poorly correlated | N/A | ||
More | ||||
VRBCF and
Correlation & Price change
A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.
| Ticker / NAME | Correlation To VRBCF | 1D Price Change % | ||
|---|---|---|---|---|
| VRBCF | 100% | N/A | ||
| RCDTF - VRBCF | 56% Loosely correlated | N/A | ||
| OGN - VRBCF | 1% Poorly correlated | -1.83% | ||
| MIRA - VRBCF | 1% Poorly correlated | +2.67% | ||
| CSWYF - VRBCF | 0% Poorly correlated | N/A | ||
| JCRRF - VRBCF | -0% Poorly correlated | N/A | ||
More | ||||